Sandesh Seth, Director at RELMADA THERAPEUTICS, INC. (RLMD), bought 10,500 shares at $3.00 ($31K) on 2015-12-14, disclosed to the SEC on 2015-12-16.
Open-market purchase of $31k RLMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.50 | 800 | $2K | 6.5% |
| 2 | $2.50 | 140 | $350 | 1.1% |
| 3 | $2.89 | 1,560 | $5K | 14.7% |
| 4 | $2.90 | 500 | $1K | 4.7% |
| 5 | $2.97 | 1,000 | $3K | 9.7% |
| 6 | $2.99 | 5,000 |
| $15K |
| 48.7% |
| 7 | $3.00 | 1,500 | $5K | 14.6% |
| Total | $2.93 avg | 10,500 | $31K | 100% |
| Filing → |
| ATNM | BUY | 2018-04-20 | $2K | — | Filing → |
| ATNM | BUY | 2017-08-04 | $25K | — | Filing → |
| ATNM | BUY | 2017-06-15 | $9K | — | Filing → |